Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05361837 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Aug 15, 2024 to Nov 15, 2026
    • Study completion date: Aug 25, 2024 to Nov 25, 2026
    • Site details revised
    v8
  2. Primary completion date: Mar 15, 2024 to Aug 15, 2024
    • Study completion date: Apr 25, 2024 to Aug 25, 2024
    v7
  3. Primary completion date: Nov 15, 2023 to Mar 15, 2024
    • Study completion date: Dec 25, 2023 to Apr 25, 2024
    v6
  4. Primary completion date: May 15, 2023 to Nov 15, 2023
    • Study completion date: May 25, 2023 to Dec 25, 2023
    v5
  5. Primary completion date: Feb 15, 2023 to May 15, 2023
    • Study completion date: Feb 25, 2023 to May 25, 2023
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Dec 15, 2022 to Feb 15, 2023
    • Study completion date: Dec 25, 2022 to Feb 25, 2023
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 28, 2022 to May 10, 2022
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.
Trial Details
NCT Number NCT05361837
Lead Sponsor National Cancer Institute, Egypt
Conditions
(from sponsor)		 Analgesia
Related terms Agnosia
Enrollment 172 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov